[Pembrolizumab in adjuvant therapy in non-small cell lung cancers]

Antoine Lefèvre; Claire Tissot

doi:10.1016/j.bulcan.2023.12.012

[Pembrolizumab in adjuvant therapy in non-small cell lung cancers]

Bull Cancer. 2024 Apr;111(4):334-336. doi: 10.1016/j.bulcan.2023.12.012. Epub 2024 Mar 11.

[Article in French]

Authors

Antoine Lefèvre¹, Claire Tissot²

Affiliations

¹ Département d'oncologie médicale, Gustave-Roussy, université Paris-Saclay, 94805 Villejuif, France. Electronic address: antoinel97@hotmail.fr.
² Hôpital privé de la Loire, 42100 Saint-Étienne, France.

PMID: 38471995
DOI: 10.1016/j.bulcan.2023.12.012

No abstract available

Keywords: Adjuvant therapy; Cancer bronchique non à petites cellules; Immunotherapy; Immunothérapie; Non-small cell lung cancer; Pembrolizumab; Traitement adjuvant.

Publication types

Letter

MeSH terms

Antibodies, Monoclonal, Humanized
Carcinoma, Non-Small-Cell Lung* / drug therapy
Humans
Immunotherapy
Lung Neoplasms* / drug therapy
Nivolumab

Substances

pembrolizumab
Antibodies, Monoclonal, Humanized
Nivolumab